Cargando…
Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
PURPOSE: The potential of members of the epidermal growth factor receptor (ErbB) family as drug targets in cholangiocarcinoma (CCA) has not been extensively addressed. Although phase III clinical trials showed no survival benefits of erlotinib in patients with advanced CCA, the outcome of the standa...
Autores principales: | Boonsri, Boonyakorn, Yacqub-Usman, Kiren, Thintharua, Pakpoom, Myint, Kyaw Zwar, Sae-Lao, Thannicha, Collier, Pam, Suriyonplengsaeng, Chinnawut, Larbcharoensub, Noppadol, Balasubramanian, Brinda, Venkatraman, Simran, Egbuniwe, Isioma U., Gomez, Dhanwant, Mukherjee, Abhik, Kumkate, Supeecha, Janvilisri, Tavan, Zaitoun, Abed M, Kuakpaetoon, Thiti, Tohtong, Rutaiwan, Grabowska, Anna M, Bates, David O., Wongprasert, Kanokpan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053863/ https://www.ncbi.nlm.nih.gov/pubmed/33070556 http://dx.doi.org/10.4143/crt.2020.585 |
Ejemplares similares
-
Dysregulation of microRNA in cholangiocarcinoma identified through a meta-analysis of microRNA profiling
por: Likhitrattanapisal, Somsak, et al.
Publicado: (2020) -
Targeting FGFRs Using PD173074 as a Novel Therapeutic Strategy in Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2023) -
Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma
por: Balasubramanian, Brinda, et al.
Publicado: (2021) -
Downregulation of ABCA1 and ABCG1 transporters by simvastatin in cholangiocarcinoma cells
por: Seeree, Pattaya, et al.
Publicado: (2019) -
An Omics Perspective on Molecular Biomarkers for Diagnosis, Prognosis, and Therapeutics of Cholangiocarcinoma
por: Seeree, Pattaya, et al.
Publicado: (2015)